US Capital Global Securities Launches $10MM Convertible Note Offering for QT Imaging, Inc.

US Capital Global Securities engaged as lead placement agent by innovative MedTech company developing new-paradigm ultrasound technology for breast cancer screening.

US Capital Global Securities LLC, an affiliate of US Capital Global, is offering to eligible investors an investment opportunity of up to $10 million in QT Imaging, Inc. (“QT Imaging”). Founded in 2012, QT Imaging is a privately held medical device company engaged in the research, development, and commercialization of innovative body imaging systems using transmitted low-energy sound, in contrast with traditional ultrasound which uses reflective sound.

The company’s first product, the QT Breast Scanner, is FDA-cleared for whole breast imaging. The technology can be used for medical screening, diagnosis, and as a treatment platform for image-guided procedures, including a novel approach to non-surgical treatment of early-stage breast cancer. QT Imaging’s next products, point-of-care orthopedic and infant imaging systems, aim to provide the first 100% safe body imaging systems.

With offices in San Francisco and London, US Capital Global is a full-service private financial group with an established track record in investment banking, asset management, and capital formation services. All securities are offered by the group through its FINRA-member, SEC-registered broker-dealer affiliate, US Capital Global Securities LLC.

“We are thrilled to be partnering with US Capital Global Securities on this $10 million convertible note offering,” said John C. Klock, M.D., CEO and Chief Medical Officer of QT Imaging. “US Capital Global has a reputation for supporting innovative medical and technological advancements, and we are proud to be presenting the industry with our unique NIH-funded, FDA 501(K) cleared transmission ultrasound technology utilizing 3D acquisition and reconstruction. This will go a long way to improve screening, diagnosis, and patient experience in breast and body imaging, all while lowering costs.

“95% of all mammogram positives are false positives, and for every person diagnosed with breast cancer, 19 more will receive abnormal results when nothing is wrong. The resulting cost, time, and psychological distress takes an enormous toll. We exist to change the paradigm of breast imaging and prevent women from undergoing the trauma of this ordeal.

“Our QTscan®, now proven in clinical trials to have better sensitivity and specificity, can safely identify the difference between benign and problematic tissue without the need for compression, injections, and potentially harmful radiation. The financing from this convertible note raise will allow us to secure additional clearances for our QTscan, fund production ramp up, and support improvements to the device, which will also accelerate development of our body imaging systems.”

Charles Towle, CEO at US Capital Global Securities, said: “QT Imaging is playing a vital role in the development of more advanced, accurate, non-invasive body scanning technology, and we are proud to support the company in its MedTech developments. QT Imaging competes in the large and growing medical imaging market, which is estimated at $40 billion globally and $10 billion in the United States annually. The company has already received recognition for its QT Scan and been awarded over $15 million in funding by the National Institute of Health to continue its product development. If you are interested in QT Imaging, the opportunity to participate in this $10 million convertible note offering is now open to eligible investors.”

About QT Imaging

About US Capital Global

To learn more about this investment opportunity, email Frank Villarreal, Vice President, at fvillarreal@uscapglobal.com or call +1 415–350–4092.

CEO of US Capital Global, a full-service private financial group, and a supporter of tech innovations that can help to improve and grow the finance sector.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store